GSK CEO Witty new president of EFPIA
This article was originally published in SRA
GlaxoSmithKline chief executive Andrew Witty has succeeded Bayer Healthcare chief executive Arthur Higgins as president of EFPIA, the European federation of pharmaceutical industries and associations.
You may also be interested in...
Novartis seems to have accepted the fact that the indication granted for Piqray in the EU means there is little scope for the advanced breast cancer drug to be used in markets such as the UK.
Sanofi failed in its attempt to have its EU marketing authorization application for avalglucosidase alfa fast-tracked through the centralized review process at the European Medicines Agency. This and other developments relating to the agency's accelerated assessment mechanism are logged in this latest update to the Pink Sheet's EU accelerated assessment tracker.
Change in leadership at the European Medicines Agency comes at a critical time.